3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Hodgkin Disease
12
Lymphoma
10
Testicular Neoplasms
2
Teratoma
2
Endodermal Sinus Tumor
2
Testicular Germ Cell Tumor
1
Sertoli-Leydig Cell Tumor
1
Recurrence
1
Ovarian gynandroblastoma
1
Ovarian Germ Cell Cancer
1
Lymphoma, Follicular
1
HIV Infections
1
Granulosa cell tumor of the ovary
1
Gliosarcoma
1
Glioblastoma
1
Central Nervous System Neoplasms
1
Carcinoma, Embryonal
1
Breast Neoplasms
1
Interventions
Cisplatin
32
human papillomavirus vaccine, L1 type 16, 18
16
Brachytherapy
15
Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
12
Paclitaxel
11
Bevacizumab
11
pembrolizumab
10
Platinum
9
1,2-diaminocyclohexaneplatinum II citrate
9
Topotecan
8
Radiotherapy, Intensity-Modulated
8
Radiation
8
Papillomavirus Vaccines
8
atezolizumab
6
Gemcitabine
6
Fluorodeoxyglucose F18
6
Cyclophosphamide
6
tisotumab vedotin
5
fludarabine phosphate
5
fludarabine
5
aldesleukin
5
Taxes
5
Radiotherapy
5
Magnetic Resonance Spectroscopy
5
Carboplatin
5
Vaccines, Synthetic
4
Nivolumab
4
Immunoglobulin G
4
Disulfides
4
Colposcopy
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Uterine Cervical Neoplasms
×
Bleomycin
×
Clear all
No trials found.